JOA - 2026-08-10 - Journal Article
Comparison of Postoperative Outcomes Following Simultaneous versus Staged Bilateral Total Knee Arthroplasty in Obese Patients: A Database Study.
Patel D, Gay S, Belzile E, Barimani B, Albers A, Mutch J
Topics
Key Takeaway
In BMI ≥40 patients undergoing bilateral TKA, staged versus simultaneous surgery reduced 30-day composite complications (OR 0.18), two-year aseptic loosening (OR 0.24), and all-cause revision (OR 0.13).
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study compared 30-day and 2-year outcomes of simultaneous versus staged bilateral TKA across four BMI categories in 11,965 patients from a global de-identified research network (2014–2024). BMI category significantly modified the effect of surgical timing on composite complications, readmission, aseptic loosening, revision, and LOS (all interaction p<0.05). Staged BTKA conferred progressively greater protection against complications and revision as BMI increased, with the largest absolute risk reductions in class 3 obesity, while non-obese patients undergoing staged BTKA paradoxically had higher 30-day readmission (OR 1.93).
Key Limitation
The de-identified database cannot confirm that staging was planned versus dictated by perioperative complications, meaning selection bias may inflate the apparent benefit of staged surgery in high-BMI patients.
Original Abstract
BACKGROUND
Obesity is associated with higher complication risk after total knee arthroplasty (TKA), and evidence comparing simultaneous versus staged bilateral TKA (BTKA) across obesity severity is limited.
METHODS
Adults undergoing BTKA (2014 to 2024) were identified from a global de-identified research network. Patients were classified by surgical timing (simultaneous; short-interval staged [one to less than four months]; longer-interval staged [four to 12 months]) and body mass index (BMI) (non-obese [less than 30]; obesity classes 1 [30 to less than 35]; 2 [35 to less than 40]; 3 [greater than 40]). Both 30-day and two-year outcomes were evaluated using logistic and linear regressions adjusted for age, sex, ethnicity, and Charlson comorbidity score with interaction testing between BMI category and surgical timing.
RESULTS
Among 11,965 patients (5,653 non-obese; 3,096 class 1; 1,870 class 2; 1,346 class 3), BMI category modified surgical timing's association with 30-day composite complications (P < 0.001), readmission (P = 0.017), two-year aseptic loosening (P = 0.011), all-cause revision (P = 0.011) and length of stay (LOS) (P < 0.001). Staged BTKA showed lower odds of composite complications with the largest reductions in class 3 (short-interval [odds ratio (OR) 0.18, 95% confidence interval (CI): 0.09 to 0.35]; comparable for longer-interval). Staged BTKA also showed lower odds of aseptic loosening and revision in classes 2 and 3 with the largest reductions in class 3 (aseptic loosening [OR 0.24, 95% CI: 0.08 to 0.71]; revision [OR 0.13, 95% CI: 0.04 to 0.42]; comparable for longer-interval). In non-obese patients, staged BTKA was conversely associated with higher 30-day readmission ([OR 1.93, 95% CI: 1.17 to 3.17]; comparable for longer interval). The LOS was longer after simultaneous than staged BTKA, decreasing at higher BMI.
CONCLUSION
The BMI category modified surgical timing's association with postoperative outcomes. Staged BTKA showed reductions in 30-day composite complications from class 1 onward and in two-year aseptic loosening and all-cause revision at BMI ≥ 35. The largest reductions for all three outcomes were observed in class 3.